HER2-targeted CAR T-cell therapy (locoregional)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HER2-targeted CAR T-cell therapy (locoregional), covering 2025-12-17 to 2025-12-17. Get the full timeline:
Most recent: Clinical Trial Update: HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors [Phase 1]